Ingevity Corporation $NGVT Position Trimmed by Leeward Investments LLC MA

Leeward Investments LLC MA lessened its position in shares of Ingevity Corporation (NYSE:NGVT – Free Report) by 5.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 153,075 shares of the company’s stock after selling 9,459 shares during the period. Leeward Investments LLC MA owned approximately 0.45% of Ingevity worth $10,830,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Canada Pension Plan Investment Board acquired a new stake in Ingevity during the 2nd quarter worth approximately $1,113,000. Principal Financial Group Inc. raised its holdings in Ingevity by 4.0% in the first quarter. Principal Financial Group Inc. now owns 678,037 shares of the company’s stock valued at $48,297,000 after buying an additional 25,800 shares during the period. Illinois Municipal Retirement Fund purchased a new position in Ingevity in the first quarter valued at approximately $1,465,000. Hsbc Holdings PLC purchased a new position in Ingevity in the second quarter valued at approximately $1,568,000. Finally, The Manufacturers Life Insurance Company acquired a new position in Ingevity during the second quarter valued at approximately $1,305,000. Hedge funds and other institutional investors own 91.59% of the company’s stock.

Wall Street Analyst Weigh In

NGVT has been the subject of several research reports. Weiss Ratings downgraded shares of Ingevity from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday. Wall Street Zen lowered shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 1st. Two analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $80.00.

Read Our Latest Analysis on Ingevity

Insider Activity at Ingevity

In related news, SVP Ryan Fisher sold 2,709 shares of the business’s stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $73.72, for a total transaction of $199,707.48. Following the transaction, the senior vice president directly owned 15,722 shares of the company’s stock, valued at approximately $1,159,025.84. The trade was a 14.70% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO David Li sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $75.83, for a total value of $379,150.00. Following the completion of the transaction, the chief executive officer owned 120,636 shares of the company’s stock, valued at approximately $9,147,827.88. This represents a 3.98% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 17,801 shares of company stock worth $1,347,481 over the last three months. 0.88% of the stock is currently owned by corporate insiders.

Ingevity Stock Up 0.1%

Shares of NYSE NGVT opened at $69.73 on Monday. The stock has a fifty day moving average price of $70.28 and a 200 day moving average price of $71.85. The company has a current ratio of 1.61, a quick ratio of 1.15 and a debt-to-equity ratio of 22.52. Ingevity Corporation has a 12-month low of $45.85 and a 12-month high of $79.29. The company has a market cap of $2.40 billion, a P/E ratio of 47.44 and a beta of 1.14.

Ingevity (NYSE:NGVT – Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $1.74 EPS for the quarter, topping analysts’ consensus estimates of $1.33 by $0.41. The company had revenue of $314.10 million for the quarter, compared to analysts’ expectations of $312.20 million. Ingevity had a return on equity of 284.70% and a net margin of 4.65%. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Research analysts anticipate that Ingevity Corporation will post 5.40 EPS for the current fiscal year.

About Ingevity

(Free Report)

Ingevity Corporation (NYSE: NGVT) is a specialty chemicals and materials company that develops products designed to improve performance, efficiency, and sustainability across a range of industrial and consumer applications. Its offerings serve markets including automotive, transportation, agriculture, coatings, adhesives, pavement markings, and industrial manufacturing.

The company is best known for activated carbon products used in automotive vapor-emission control systems, where they help capture fuel vapors and reduce emissions.

Read More

Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corporation (NYSE:NGVT – Free Report).

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.